Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio Pockets Undisclosed Private Investment for Product Development

NEW YORK (GenomeWeb News) — Bioinformatics shop CLC Bio has received an undisclosed amount of new financial backing from several new private Danish investors, the company said today.
 
The new backers include Peter Bogild, Tom Nordin, and Thomas Bruno, who have a combined capital base of $200 million, the company said.
 
CLC Bio will use the funding to continue developing software for next-generation sequencing and to continue to enhance its current product line, company CEO Thomas Knudsen said.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.